Target Price | $301.92 |
Price | $271.28 |
Potential |
11.29%
register free of charge
|
Number of Estimates | 18 |
18 Analysts have issued a price target CME Group a 2026 .
The average CME Group a target price is $301.92.
This is
11.29%
register free of charge
$328.65
21.15%
register free of charge
$214.12
21.07%
register free of charge
|
|
A rating was issued by 22 analysts: 10 Analysts recommend CME Group a to buy, 9 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CME Group a stock has an average upside potential 2026 of
11.29%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 10.21 | 6.58 |
5.94% | 35.57% | |
EBITDA Margin | 81.76% | 70.46% |
2.08% | 13.82% | |
Net Margin | 34.10% | 61.75% |
16.19% | 81.08% |
19 Analysts have issued a sales forecast CME Group a 2025 . The average CME Group a sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an CME Group a EBITDA forecast 2025. The average CME Group a EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 CME Group a Analysts have issued a net profit forecast 2025. The average CME Group a net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 9.67 | 11.27 |
9.14% | 16.55% | |
P/E | 24.07 | |
EV/Sales | 15.06 |
20 Analysts have issued a CME Group a forecast for earnings per share. The average CME Group a EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Locked
➜
Locked
|
Locked | Oct 08 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Oct 01 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Sep 25 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Sep 25 2025 |
UBS |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
UBS |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Analyst Rating | Date |
---|---|
Locked
Barclays:
Locked
➜
Locked
|
Oct 08 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Oct 01 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Sep 25 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 25 2025 |
Locked
UBS:
Locked
➜
Locked
|
Sep 08 2025 |
Locked
UBS:
Locked
➜
Locked
|
Jul 24 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
Jul 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.